Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients [NA]
A completed clinical trial update examining the emotional needs of caregivers of stem cell transplantation patients is reported.
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma [Phase 2]
Phase 2 trial evaluating high-dose sequential therapy with autologous stem cell rescue in multiple myeloma; study completed.
-
CLINICAL_TRIALS trial_result · 2010-08-13Clinical Trial Update: AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone [Phase 2]
Phase 2 trial of plerixafor (AMD3100) in multiple myeloma or non-Hodgkin lymphoma patients predicted to be unable to mobilize with G-CSF alo…
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluating high-dose busulfan and high-dose cyclophosphamide conditioning followed by donor bone marrow transplantation in p…
-
CLINICAL_TRIALS trial_result · 2010-08-02Clinical Trial Update: Study of Combination PS-341 and Thalidomide in Multiple Myeloma [Phase 1]
Phase 1 clinical trial assessing the combination of PS-341 (bortezomib) and thalidomide in patients with multiple myeloma; the study status …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2010-07-28Clinical Trial Update: The Pathophysiology of Bortezomib Induced Peripheral Neuropathy
An update on the pathophysiology of bortezomib-induced peripheral neuropathy in patients with multiple myeloma, outlining the mechanisms of …
-
CLINICAL_TRIALS trial_result · 2010-07-14Clinical Trial Update: Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients [Phase 2]
Phase 2 trial evaluating stem cell mobilization using plerixafor in combination with chemotherapy and G-CSF in patients with multiple myelom…
-
CLINICAL_TRIALS trial_result · 2010-07-08Clinical Trial Update: Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma [Phase 2]
A Phase 2 clinical trial evaluating pegfilgrastim for stem cell mobilization in lymphoma and multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-07Clinical Trial Update: Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally [Phase 2]
A Phase 2 clinical trial evaluating a tumor antigen-pulsed autologous dendritic cell vaccine administered subcutaneously or intranodally in …
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide [Phase 2]
A Phase 2 clinical trial evaluating the combination of pamidronate and thalidomide for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-02Clinical Trial Update: DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse [Phase 2]
Phase 2 study evaluating DCEP (dexamethasone, cisplatin, etoposide, cyclophosphamide) in combination with thalidomide as salvage therapy for…
-
CLINICAL_TRIALS trial_result · 2010-07-02Clinical Trial Update: Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy [Phase 2]
Phase 2 trial evaluating dexamethasone alone or in combination with thalidomide as salvage therapy for multiple myeloma; the study is comple…
-
CLINICAL_TRIALS trial_result · 2010-07-02Clinical Trial Update: Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating thalidomide as an anti-angiogenesis therapy in multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-02Clinical Trial Update: D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma [Phase 3]
Phase 3 trial update comparing the D.T. PACE chemotherapy regimen against high-dose melphalan with autologous transplant in patients with pr…
-
CLINICAL_TRIALS trial_result · 2010-07-02Clinical Trial Update: Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II [Phase 3]
A Phase 3 trial evaluating the combination of bortezomib and lenalidomide (Revlimid) for patients with multiple myeloma who relapsed or prog…
-
CLINICAL_TRIALS research · 2010-07-02Clinical Trial Update: An Open Protocol for the Compassionate Use of Thalidomide [Phase 1, Phase 2]
Clinical trial update for an open compassionate-use protocol using thalidomide in multiple myeloma patients across Phase 1 and Phase 2. The …
-
CLINICAL_TRIALS trial_result · 2010-06-29Clinical Trial Update: Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma [Phase 2]
This update reports results from a Phase 2 study evaluating weekly bortezomib (Velcade) in patients with refractory multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients [Phase 3]
A Phase 3 trial evaluated whether consolidating with bortezomib after high-dose melphalan with stem cell support improves outcomes in multip…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Bortezomib and High-dose Melphalan at Myeloma Relapse [Phase 2]
Clinical trial update for a Phase 2 study evaluating bortezomib combined with high-dose melphalan for relapsed multiple myeloma. The current…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma [Phase 2]
Phase II trial evaluating the combination of O6-benzylguanine and carmustine in patients with multiple myeloma. The study has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
A Phase 2 trial evaluating high-dose chemotherapy followed by peripheral stem cell transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma [Phase 2]
A Phase 2 study comparing two VELCADE-based regimens (VDT vs VDTC) in combination with dexamethasone, thalidomide, and cyclophosphamide for …
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy [Phase 3]
This Phase 3 trial update reports on an influenza A(H1N1) vaccine evaluated in adults with lymphoid malignancies undergoing chemotherapy. Th…
-
CLINICAL_TRIALS trial_result · 2010-05-13Clinical Trial Update: Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [Phase 2]
A Phase 2 trial evaluating tacrolimus and mycophenolate mofetil to prevent acute graft-versus-host disease in patients with advanced hematol…
-
CLINICAL_TRIALS trial_result · 2010-05-06Clinical Trial Update: A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation [Phase 2]
Phase 2 study evaluating Lupron Depot to enhance immune function after bone marrow transplantation was terminated, with results posted in 20…